Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 75 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Written informed consent
Male and female patients, aged between 18 and 75 years
Metabolic syndrome according to National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII)
History of heart failure
Other protocol defined inclusion and exclusion criteria may apply.